Denis Leonardo Fontes Jardim

Summary

Affiliation: Hospital Sirio Libanes
Location: Sao Paulo, Brazil
Summary:
Clinical Oncologista at Sirio Libanes Hospital.
Researcher at Sirio Libanes Hospital and State University of Campinas, interested in mechanisms of drug resistance and development of new drugs for cancer treatment

Publications

  1. ncbi Expression of Sara2 human gene in erythroid progenitors
    Denis Leonardo Fontes Jardim
    State University of Campinas, Center of Hemotherapy and Hematology, Campinas, SP, 13083 970, Brazil
    J Biochem Mol Biol 38:328-33. 2005
  2. doi Haematologic toxicities associated with the addition of bevacizumab in cancer patients
    Fabio A B Schutz
    Kidney Cancer Center, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA
    Eur J Cancer 47:1161-74. 2011
  3. ncbi Autoimmune features caused by dengue fever: a case report
    Denis Leonardo Fontes Jardim
    Department of Internal Medicine, Universidade Estadual de Campinas, Campinas, SP, Brazil
    Braz J Infect Dis 16:92-5. 2012
  4. doi Factors associated with failure of oncology drugs in late-stage clinical development: A systematic review
    Denis L Jardim
    Department of Clinical Oncology, Hospital Sirio Libanes, Sao Paulo, Brazil Electronic address
    Cancer Treat Rev 52:12-21. 2017
  5. pmc Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities
    Denis L Fontes Jardim
    Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, FC8 3038, Box 0455, Houston, TX 77030, USA
    Orphanet J Rare Dis 8:112. 2013
  6. pmc Bevacizumab as first-line therapy in advanced non-small-cell lung cancer: a brazilian center experience
    Denis Leonardo Fontes Jardim
    Department of Clinical Oncology, Hospital Sirio Libanes, Sao Paulo, Brazil
    Drugs R D 12:207-16. 2012

Collaborators

Detail Information

Publications7

  1. ncbi Expression of Sara2 human gene in erythroid progenitors
    Denis Leonardo Fontes Jardim
    State University of Campinas, Center of Hemotherapy and Hematology, Campinas, SP, 13083 970, Brazil
    J Biochem Mol Biol 38:328-33. 2005
    ..Our results suggest that Sara2 is an important gene in processes involving proliferation and differentiation and could be valuable for understanding the vesicular transport system during erythropoiesis...
  2. doi Haematologic toxicities associated with the addition of bevacizumab in cancer patients
    Fabio A B Schutz
    Kidney Cancer Center, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA
    Eur J Cancer 47:1161-74. 2011
    ..We performed a meta-analysis to determine the incidence and risk of haematologic toxicities associated with bevacizumab...
  3. ncbi Autoimmune features caused by dengue fever: a case report
    Denis Leonardo Fontes Jardim
    Department of Internal Medicine, Universidade Estadual de Campinas, Campinas, SP, Brazil
    Braz J Infect Dis 16:92-5. 2012
    ..Therefore, dengue should be suspected in patients with hematological disorders and autoimmune features in endemic regions or those who have travelled to those regions...
  4. doi Factors associated with failure of oncology drugs in late-stage clinical development: A systematic review
    Denis L Jardim
    Department of Clinical Oncology, Hospital Sirio Libanes, Sao Paulo, Brazil Electronic address
    Cancer Treat Rev 52:12-21. 2017
    ..We aimed to describe the reasons for failure of experimental anticancer drugs in late-stage clinical development...
  5. pmc Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities
    Denis L Fontes Jardim
    Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, FC8 3038, Box 0455, Houston, TX 77030, USA
    Orphanet J Rare Dis 8:112. 2013
    ....
  6. pmc Bevacizumab as first-line therapy in advanced non-small-cell lung cancer: a brazilian center experience
    Denis Leonardo Fontes Jardim
    Department of Clinical Oncology, Hospital Sirio Libanes, Sao Paulo, Brazil
    Drugs R D 12:207-16. 2012
    ..A single Latin American center experience was reviewed to determine the safety and efficacy of adding bevacizumab to first-line chemotherapy in a local population...